MADRIGAL PHARMACEUTICALS, INC. (MDGL) insider trading

By person

17 insiders · 193 transactions

117×

Bill Sibold holds 117 times base salary in stock. $108.04M of shares against $918.53K in salary for 2025.

Salary from the company's own proxy. The shares are what Bill Sibold last reported holding, valued at $546.38, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Paul A Friedman

Director

—

$26.66M (38) scheduled

−$26.66M

187,164

0.8101%

$102.26M

+0.4%

Rebecca Taub

Director

—

$21.68M (42) scheduled

−$21.68M

452,667

1.96%

$247.33M

−1.4%

William John Sibold

President and CEO

—

$10.48M (37) scheduled

−$10.48M

197,746

0.8559%

$108.04M

+253.8%

Richard S Levy

Director

—

$7.36M (26) scheduled

−$7.36M

22,469

0.0973%

$12.28M

+104.0%

Mardi Dier

EVP and CFO

—

$3.77M (28) scheduled

−$3.77M

12,490

0.0541%

$6.82M

+40.7%

Carole Huntsman

Chief Commercial Officer

—

$1.71M (14) scheduled

−$1.71M

12,692

0.0549%

$6.93M

+10.6%

David Soergel

Chief Medical Officer

—

$951.98K (2) scheduled

−$951.98K

10,033

0.0434%

$5.48M

—

Shannon T Kelley

General Counsel

—

$841.61K (4)

−$841.61K

11,474

0.0497%

$6.27M

+43.7%

Baker Bros. Advisors LP entity

Director

—

1,948,876

8.44%

$1.06B

+9.6%

Fred B Craves

Director

—

361,076

1.56%

$197.28M

−1.9%

Robert E. Waltermire

Senior VP, Chief Pharma Dev.

—

5,789

0.0251%

$3.16M

+5.3%

James M Daly

Director

—

3,081

0.0133%

$1.68M

+61.1%

Kenneth Bate

Director

—

2,627

0.0114%

$1.44M

+37.4%

Rita Thakkar

Chief Accounting Officer

—

2,398

0.0104%

$1.31M

—

Jacqualyn A Fouse

Director

—

1,551

0.0067%

$847.43K

—

Daniel J. Brennan

Director

—

1,371

0.0059%

$749.08K

—

John C Reed

Director

—

647

0.0028%

$353.51K

—

MADRIGAL PHARMACEUTICALS, INC.

What the insiders did Net selling

By person